Navigation Links
For the first time, researchers identify and isolate adult mammary stem cells in mice
Date:8/30/2010

SEATTLE For the first time, researchers at Fred Hutchinson Cancer Research Center have identified and isolated adult mammary stem cells in mice. Long-term implications of this research may include the use of such cells to regenerate breast tissue, provide a better understanding of the role of adult stem cells in breast cancer development, and develop potential new targets for anti-cancer drugs.

The findings, by Larry Rohrschneider, Ph.D., a member of the Basic Sciences Division at the Hutchinson Center, and Lixia Bai, M.D., Ph.D., a research associate in his lab, are published in the Sept. 1 issue of Genes & Development.

Using a genetically modified mouse model, the researchers tagged stem cells with green fluorescent protein (GFP), which exhibits bright green fluorescence during gene expression and can be easily seen under a microscope. GFP expression is controlled by the promoter of a newly identified gene, specifically expressed in stem cells, called s-SHIP.

Until now, we have not been able to identify stem cells in mammary tissue. They have never been detected before with such specificity. It is extraordinary. You can see these green stem cells under the microscope in their pure, natural state, said Rohrschneider, who has filed a patent on the s-SHIP promoter-GFP-labeling technology.

Previous systems for isolating stem cells have relied on a variety of biomarkers, none of which have yielded a pure stem cell population. This limitation has prohibited accurate gene-expression analysis of such cells.

The researchers demonstrated the presence of active green stem cells at crucial stages of mammary development, such as puberty and pregnancy. During quiescent stages of development, however, the cells did not "light up."

Such stem cells represent a new alternative to induced pluripotent stem cells, or genetically altered stem cells, for various medical applications.

For example, by isolating the pure green mammary cells from donor female transgenic mice, the researchers have demonstrated the regenerative ability of these cells by transplanting them into the mammary fat tissue of recipient mice whose own mammary epithelium has been removed.

"We have found that those transplanted green stem cells can generate new mammary tissue and this tissue can produce milk, just like normal mammary epithelial cells," said co-author Bai. "Identification of the exact stem cell and its location is the first critical and fundamental step toward understanding the regulatory mechanisms of these important cells."

In addition to potential clinical applications regarding tissue regeneration, the researchers see these isolated stem cells as a window to better understanding how normal stem cells can become cancer stem cells, which are hypothesized to exist in tumors.

"Our belief right now is that perhaps the most aggressive tumors may be coming from the malignant transformation of stem cells in healthy tissue," Rohrschneider said. "This new technology offers a unified model for identifying normal and cancer stem cells."

Cancer stem cells are thought to be responsible for tumor initiation, growth, metastasis, therapy resistance and disease relapse.

"Because stem cells are critical for both normal tissue development and cancer development, exploring how they are regulated in normal development will help us to better understand how they are transformed into breast cancer cells," Bai said. "By searching for new methods to effectively and specifically target cancer stem cells, we hope we can cure breast cancer someday." she said.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
2. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
3. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
4. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
5. Deaf, hard-of-hearing students perform first test of sign language by cell phone
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
7. Doctors hard to find for patients in Massachusetts first for-profit health plan
8. Scientists develop the first model for investigating the origins of testicular cancer in humans
9. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
10. Why the MRC didnt fund research that led to the birth of the worlds first test tube baby
11. UCLA scientists isolate the first stages of tissue production in human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 2017 , ... Healthful Balance announces the national release of ... by Ed Stroup, was created to offer the highest quality vitamins and supplements ... service. Healthful Balance products can be purchased online through their website, or can ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of ... will be featuring DRTV campaigns regarding the topic of Beauty and Personal Care. ... version of themselves. What better way to commit to these changes than beginning with ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development ... to infusing high speed technology into the fabric of an entire community. A ... of healthcare and wellness in a yet-to-be-named, health focused campus. Leading this initiative ...
(Date:1/17/2017)... TX (PRWEB) , ... January 17, 2017 , ... Mirror ... have earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice ... named part of this elite group of providers. , Produced by Zeltiq, CoolSculpting ...
(Date:1/17/2017)... ... 17, 2017 , ... Peoples Health is pleased to announce ... Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than ... to our provider network, and the addition will benefit our members in the ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
(Date:1/17/2017)... and Markets has announced the addition of the "The Top 200 ... ... profiles the leading 200 manufacturers and distributors of molecular diagnostics products worldwide. ... States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics Companies ...
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
Breaking Medicine Technology: